cycle
311 results
1 - 100- obinutuzumab
- carfilzomib
- isatuximab
- azaCITIDine
- naxitamab
- decitabine
- bendamustine
- cladribine
- ribociclib
- daunorubicin/cytarabine liposomal
- blinatumomab
- romiDEPsin
- elotuzumab
- antineoplastics
- PEMEtrexed
- bortezomib
- moxetumumab pasudotox
- estropipate
- gemcitabine
- durvalumab
- eriBULin
- ixazomib
- inotuzumab ozogamicin
- nelarabine
- mogamulizumab
- rituximab/hyaluronidase
- copanlisib
- temozolomide
- lapatinib
- irinotecan
- halofantrine
- capecitabine
- belinostat
- diuretics
- decitabine/cedazuridine
- ganirelix
- omacetaxine
- pertuzumab
- pemigatinib
- enfortumab vedotin
- panobinostat
- pomalidomide
- gemtuzumab ozogamicin
- nabilone
- ado-trastuzumab
- glasdegib
- infigratinib
- menotropins
- palbociclib
- clomiPHENE
- midostaurin
- polatuzumab vedotin
- pegfilgrastim
- indapamide
- nafarelin
- dinutuximab
- torsemide
- lenalidomide
- DOXOrubicin, liposomal
- mechlorethamine
- etoposide
- carmustine
- teniposide
- ramelteon
- vorinostat
- regorafenib
- glycerol phenylbutyrate
- dacarbazine
- ifosfamide
- lomustine
- tivozanib
- medroxyPROGESTERone†
- etoposide phosphate
- olaratumab
- busulfan
- chlorambucil
- cytarabine
- procarbazine
- streptozocin
- thioguanine
- clofarabine
- floxuridine
- fluorouracil
- oxaliplatin
- mechlorethamine (topical)
- CARBOplatin